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Abstract
Aim—To investigate whether mid-pregnancy inflammation predicts rate of subsequent gestational 
weight gain (GWG), and whether inflammation at 3 years postpartum is associated with weight 
and waist circumference (WC) gain during a median of 4.4 years follow-up.
Subjects & methods—We quantified CRP, IL-6, and TNF-α in plasma of 886 women at ~28 
weeks gestation, and calculated GWG rate (kg/week) from blood draw to delivery. At ~3 years 
postpartum, we assayed CRP and IL-6 from 351 women, and measured weight and WC at 3 and 7 
years postpartum. We used linear regression to investigate the relation between mid-pregnancy 
inflammation and subsequent GWG rate, and the association of inflammation at 3 years 
postpartum with weight and WC change during follow-up.
Results—After accounting for confounders, we observed a small dose-response association of 
mid-gestation CRP with subsequent GWG; women in the 4th CRP quartile gained weight at 0.05 
(95% CI: 0.01, 0.10) kg/week faster than those in the 1st quartile. Neither IL-6 nor TNF-α was 
related to GWG. Postpartum inflammation was not associated with subsequent weight or WC 
gain.
Conclusions—Higher mid-gestation CRP was related to modestly higher subsequent GWG rate. 
Future studies are warranted to confirm these findings.
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INTRODUCTION
Cross-sectional studies have consistently found a direct relation between inflammation and 
weight status (Fantuzzi, 2005). Because adipose tissue can secrete pro-inflammatory 
cytokines, inflammation is traditionally regarded as a consequence of adiposity. However, 
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some epidemiological investigations (Engstrom et al., 2003, Holz et al., 2010) found that 
low-grade inflammation preceded weight gain, suggesting that it may play a role in adipose 
accumulation. Little is known of this relation in reproductive-aged women, a population of 
special concern considering the high prevalence of overweight/obesity in this group (Flegal 
et al., 2012) and the adverse consequences of excess weight entering and during pregnancy 
for both mother and child (Oken et al., 2009).
In a longitudinal cohort, we investigated the relation of inflammation quantified during mid-
pregnancy with subsequent rate of gestational weight gain (GWG). We also examined 
whether inflammation at 3 years postpartum was associated with adiposity gain during four 
years of follow-up.
METHODS
Study population
This study included participants in Project Viva; details on recruitment and eligibility are 
previously reported (Oken et al., 2014). Women were recruited from a multi-specialty clinic 
in eastern Massachusetts (Harvard Vanguard Medical Associates) at ~10 weeks gestation. At 
enrollment, women reported their pre-pregnancy weight and height. At median 28 weeks 
gestation (‘mid-pregnancy’), participants returned for an in-person visit during which they 
provided a blood specimen. At ~3 and ~7 years postpartum, we measured the women’s 
weight (kg), waist circumference (WC; cm) using standard techniques. At the 3-year visit, 
we also collected a blood specimen.
Of the 2128 women who delivered a live singleton, we excluded those with type 1 or 2 
diabetes (n=16) from all analyses. In the first portion of this study where mid-pregnancy 
inflammation was the exposure, we also excluded 504 women who did not provide a blood 
sample during the second trimester and 82 participants with gestational diabetes. Of the 
remaining women (n=1526), inflammation biomarkers were available for 901 participants 
whose bloods were previously analyzed for a study of corticotrophin-releasing hormone and 
offspring adiposity (Gillman et al., 2006). After excluding 15 women missing information 
on GWG rate, the final analytic sample was 886.
At 3 years postpartum, inflammation data were available for 585 women whose blood 
samples were analyzed previously in a study of breastfeeding and postpartum inflammation 
(Stuebe et al., 2010). We further excluded 135 mothers who were pregnant or became 
pregnant between 2 and 7 years postpartum, and 99 participants missing data on weight and 
WC change, leaving 351 women in the postpartum analysis, 155 of whom were also in the 
mid-pregnancy analysis.
All participants provided written informed consent. The institutional review board of 
Harvard Pilgrim Health Care approved all study protocols; all procedures were conducted in 
accordance with ethical standards.
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Laboratory procedures
Blood samples were collected, processed within 24 hours, and stored at −80°C until 
analyses. Inflammatory biomarkers during mid-pregnancy (C-reactive protein [CRP], 
interleukin-6 [IL-6], tumor necrosis factor-α [TNF-α]) were assayed using a multiplex 
method described elsewhere (Luminex Corporation) (Skogstrand, 2012). At 3 years 
postpartum, CRP was measured using an immunoturbidimetric high-sensitivity assay on a 
Hitachi 911 analyzer (Roche Diagnostics). Plasma IL-6 was measured via ultrasensitive 
ELISA (R&D Systems).
Anthropometric outcomes
We obtained serial pregnancy weights from medical records and calculated GWG rate (kg/
week) as the difference between the last clinically-measured weight ≤4 weeks prior to 
delivery and weight at the time of mid-pregnancy blood draw, divided by the time difference. 
We determined weight and WC change by subtracting the anthropometric measurements at 3 
years from those at 7 years postpartum.
Covariates
Using interviews and questionnaires, we collected information on race/ethnicity, age, 
education, parity, income, breastfeeding duration, physical activity, and partner’s weight and 
height. Medical records provided information on infection during pregnancy (vaginitis and 
urinary tract infection [UTI]), birth characteristics, and delivery date. Infant birthweight-for-
gestational-age z-scores (‘fetal growth’) were determined using U.S. reference data (Oken et 
al., 2003). We calculated GWG rate prior to blood draw by dividing the difference in weight 
at blood draw and self-reported pre-pregnancy weight (kg) by time elapsed (weeks).
Data analysis
Mid-pregnancy inflammation and GWG rate—First, we examined the distribution of 
CRP, IL-6, and TNF-α across categories of sociodemographic and perinatal characteristics 
to identify confounders. Next, we estimated mean differences and 95% confidence intervals 
(CI) in GWG rate between women in the 2nd, 3rd, and 4th vs. the 1st quartile of each 
inflammation biomarker using linear regression. In multivariable analyses, we adjusted for 
gestation length and BMI at the time of blood collection, previous GWG rate, age, race/
ethnicity, education, partner’s BMI, and parity. In sensitivity analyses, we excluded 119 
women with vaginitis or UTI before or at the time of mid-pregnancy blood collection. We 
also examined associations after accounting for gestational glucose tolerance, fetal growth, 
smoking habits and physical activity during pregnancy, and preeclampsia.
Postpartum inflammation and adiposity gain—We examined the relations of CRP 
and IL-6 quartiles at 3 years postpartum with weight and WC change from 3 to 7 years 
postpartum using linear regression models that accounted for age, race/ethnicity, parity, 
education, delivery mode, breastfeeding duration, baseline anthropometry, and time elapsed 
between the anthropometric measurements. We also evaluated associations after inclusion of 
smoking habits and physical activity at 3 years postpartum. All analyses were performed 
using SAS software (v9.3; SAS Institute Inc., Cary, NC).
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RESULTS
Among the women in the mid-pregnancy inflammation analysis, median age at enrollment 
was 32.2 years (range: 14.8–44.8); 72.2% were white. Mean±SD pre-pregnancy BMI was 
24.5±5.3 kg/m2 and GWG rate from mid-pregnancy blood draw to delivery was 0.45±0.22 
kg/week.
In bivariate analyses (Table I), CRP was inversely related to education and pre-pregnancy 
physical activity; and positively associated with parity, pre-pregnancy BMI and BMI at time 
of blood draw, gestational glucose tolerance, partner’s BMI, and fetal growth. Neither IL-6 
nor TNF- α were associated with any background characteristics, except IL-6 was higher 
among multiparas and women who gained weight at a faster rate prior to blood draw, and 
TNF-α was directly related to pre-pregnancy BMI.
We observed a small dose-response relation between mid-pregnancy CRP levels and 
subsequent GWG rate after accounting for gestation length at blood draw (Table II Model 
1). GWG rate for women in the 4th CRP quartile was 0.03 (95% CI: −0.01, 0.07) kg/week 
faster than those in the 1st quartile (predicted mean±SE rate for 1st quartile=0.43±0.02 kg/
week, 4th quartile=0.46±0.01 kg/week). Adjustment for prior GWG rate and mid-pregnancy 
BMI slightly strengthened the association (Model 2). In the final model (Model 3), GWG 
rate for women in the 4th quartile was 0.05 (0.01, 0.10) kg/week greater than those in the 1st 
quartile, which corresponds to a difference of 0.7±0.3 kg total weight gain over 11.7±2.0 
weeks. These relations were similar after excluding women with an infection before or at the 
time of mid-pregnancy blood collection (4th vs. 1st quartile: 0.05 [0.00, 0.09] kg/week; P-
trend=0.04). Further adjustment for gestational glucose tolerance, fetal growth, smoking 
habits and physical activity during pregnancy, and preeclampsia did not attenuate the 
association (0.05 [0.01, 0.10] kg/week; P-trend=0.03). Neither IL-6 nor TNF-α was related 
to GWG rate.
At 3 years postpartum, sociodemographic characteristics and bivariate associations were 
similar to those presented in Table 1, with the expected increments in age and parity 
compared to the index pregnancy. Both weight (2.6±5.9 kg) and WC (2.4±6.5 cm) increased 
during the median 4.4 years follow-up, but there were no clear relations with CRP or IL-6. 
In multivariable analysis, weight change for women in the 2nd, 3rd, and 4th quartiles of CRP 
was −1.63 (−3.38, 0.12) kg, −1.36 (−3.16, 0.45) kg, and −0.95 (−2.93, 1.03) kg, as compared 
to those in the 1st quartile (P-trend=0.87). For WC change, estimates for participants in the 
2nd, 3rd, and 4th CRP quartiles were −1.41 (−3.35, 0.53) cm, −1.51 (−3.53, 0.51) cm, and 
0.23 (−1.93, 2.39) cm (P-trend=0.28). Similar associations were observed for IL-6 (data not 
shown).
DISCUSSION
In this study of U.S. reproductive-aged women, higher CRP during mid-pregnancy 
corresponded with slightly higher subsequent GWG rate. Women in the highest CRP 
quartile at mid-pregnancy gained approximately 0.6 kg more than those in the lowest 
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quartile from the time of blood draw to delivery. Neither TNF-α nor IL-6 were associated 
with weight gain during pregnancy.
Although mild inflammatory activity is normal in pregnancy (Palm et al., 2013), our finding 
with respect to CRP – although not IL-6 or TNF-α – parallels those of prospective 
investigations in non-pregnant populations (Engstrom et al., 2003, Holz et al., 2010), and 
could be explained by a few mechanisms. Researchers have speculated that although 
inflammatory cytokines initially stimulate thermogenesis through actions of regulatory 
hormones such as leptin (Bruun et al., 2002) and insulin (Xu et al., 2003), sustained 
inflammation paradoxically impairs thermogenesis by desensitizing beta-adrenergic 
signaling pathways, eventually leading to weight gain (Seals and Bell, 2004). Additionally, 
inflammation stimulates production of reactive oxidative species, which promote expansion 
and terminal differentiation of adipocytes (Lee et al., 2009). Alternatively, systemic 
inflammation may not be causally related to weight gain, but rather, marks disturbances in 
the gut microbiota that trigger hyphagia through vagal pathways between the satiety centers 
of the brain and the gastrointestinal tract (Tehrani et al., 2012).
Neither CRP nor IL-6 levels at 3 years postpartum predicted weight or WC change over 4 
years. Although a study of middle-aged adults found a direct association between CRP and 
weight gain (Holz et al., 2010), the duration of follow-up was ~10 years, meriting further 
investigation of this relation over a longer timeframe.
Strengths of this study include the ability to examine associations of inflammation with 
weight gain both during and after pregnancy. Repeated anthropometric measurements 
enhanced our ability to explore the temporal relations between the biomarkers and weight 
gain. Limitations include potential bias due to exclusion criteria and attrition, and reliance 
on a single blood draw at each time point to characterize inflammation.
In conclusion, CRP during mid-pregnancy is related to modestly higher subsequent GWG 
rate. Although the effect size was small, it is still clinically-relevant as it corresponds to 
approximately 14%, 22%, and 30% of the recommended weekly weight gain rate for normal 
weight, overweight, and obese women, respectively, during the second and third trimesters 
(Institute of Medicine, 2009). Future studies are warranted to examine this relation in other 
populations, and to explore the influence of dietary modifications and exercise to moderate 
weight gain during pregnancy.
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Table I
Distribution of inflammation biomarkers during mid-pregnancy according to background characteristics of 
886 Project Viva mothers
Mean ± SD
N*
CRP (mg/L)
n = 885
IL-6 (pg/mL)
n = 879
TNF-α (units/mg)
n = 878
Overall 1.49 ± 1.23 33.9 ± 36.7 43.6 ± 51.1
Characteristics at enrollment
Age at enrollment
 15–24 years 71 1.55 ± 1.35 29.2 ± 37.6 37.8 ± 34.2
 25–34 years 577 1.52 ± 1.26 33.7 ± 34.5 43.2 ± 51.6
 35–44 years 237 1.43 ± 1.11 35.9 ± 41.4 46.3 ± 54.0
 P† 0.32 0.19 0.22
Race/ethnicity
 Black 129 1.80 ± 1.40 29.8 ± 39.7 41.4 ± 53.0
 Hispanic 57 1.36 ± 1.08 38.3 ± 40.4 45.3 ± 40.7
 White 635 1.47 ± 1.22 34.0 ± 35.0 43.4 ± 50.3
 Asian 36 0.78 ± 0.54 33.2 ± 35.6 52.4 ± 67.0
 Other 23 1.84 ± 0.82 41.1 ± 53.1 40.4 ± 40.6
 P† 0.0001 0.51 0.83
Marital status
 Married/cohabiting 819 1.50 ± 1.23 33.8 ± 36.1 44.0 ± 49.8
 Single 62 1.37 ± 1.12 36.0 ± 45.2 35.7 ± 60.0
 P† 0.40 0.65 0.21
Education
 Primary 91 1.67 ± 1.29 39.5 ± 48.0 38.3 ± 50.1
 Secondary 549 1.55 ± 1.28 31.3 ± 33.1 43.9 ± 52.2
 University 242 1.30 ± 1.06 37.7 ± 39.3 44.6 ± 47.0
 P† 0.004 0.53 0.40
Smoking habits
 Never 616 1.50 ± 1.25 33.9 ± 36.5 44.0 ± 52.8
 Quit before pregnancy 165 1.39 ± 1.11 33.2 ± 33.2 42.1 ± 42.6
 Smoked in early pregnancy 100 1.65 ± 1.28 35.4 ± 44.0 43.8 ± 54.5
 P† 0.25 0.90 0.92
Partner’s BMI
 Not overweight (<25 kg/m2) 311 1.34 ± 1.18 32.1 ± 33.8 43.4 ± 53.9
 Overweight (≥25 kg/m2) 543 1.59 ± 1.24 34.6 ± 37.2 43.8 ± 48.5
 P† 0.004 0.34 0.89
Parity
 0 432 1.41 ± 1.18 33.2 ± 32.1 43.0 ± 49.7
 1 317 1.55 ± 1.23 31.6 ± 33.4 42.3 ± 52.4
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Mean ± SD
N*
CRP (mg/L)
n = 885
IL-6 (pg/mL)
n = 879
TNF-α (units/mg)
n = 878
 ≥2 137 1.66 ± 1.36 41.7 ± 53.6 48.8 ± 52.5
 P† 0.02 0.09 0.38
Pre-pregnancy BMI
 Underweight (<18.5 kg/m2) 31 1.28 ± 1.00 41.7 ± 47.3 37.9 ± 49.4
 Normal (18.5 to 24.9 kg/m2) 553 1.22 ± 1.09 33.4 ± 34.4 42.4 ± 46.4
 Overweight (25.0 – 29.9 kg/m2) 180 1.80 ± 1.23 34.2 ± 38.6 39.9 ± 43.5
 Obese (≥30.0 kg/m2) 120 2.34 ± 1.37 33.6 ± 37.5 54.6 ± 72.9
 P† <0.0001 0.75 0.05
Pre-pregnancy physical activity
 Q1 (lowest) 185 1.66 ± 1.31 38.3 ± 47.6 45.3 ± 60.8
 Q2 178 1.56 ± 1.26 30.7 ± 30.9 38.9 ± 45.7
 Q3 173 1.31 ± 1.05 34.5 ± 36.0 49.0 ± 56.6
 Q4 (highest) 200 1.49 ± 1.30 34.0 ± 33.1 44.1 ± 44.1
 P† 0.05 0.45 0.72
Pregnancy conditions & outcomes
GWG rate prior to blood draw (kg/week)
 Q1 (median: 0.22) 220 1.53 ± 1.31 29.0 ± 28.5 40.0 ± 51.0
 Q2 (median: 0.34) 223 1.47 ± 1.22 33.0 ± 33.9 43.9 ± 49.1
 Q3 (median: 0.41) 222 1.30 ± 1.11 36.8 ± 41.9 44.5 ± 55.6
 Q4 (median: 0.53) 221 1.68 ± 1.25 37.0 ± 40.7 46.1 ± 48.5
 P† 0.49 0.01 0.22
BMI at time of blood draw (kg/m2)
 Q1 (median: 23.3) 222 1.07 ± 1.10 31.6 ± 31.9 40.1 ± 45.8
 Q2 (median: 26.0) 220 1.27 ± 1.08 33.0 ± 33.3 41.6 ± 49.6
 Q3 (median: 28.7) 220 1.48 ± 1.13 35.5 ± 39.6 45.8 ± 46.2
 Q4 (median: 33.7) 222 2.14 ± 1.31 35.6 ± 41.3 46.3 ± 59.5
 P† <0.0001 0.19 0.14
Infection status
 Vaginitis or UTI 119 1.49 ± 1.04 34.8 ± 36.1 44.4 ± 52.9
 Neither 767 1.50 ± 1.26 33.8 ± 36.8 43.5 ± 50.8
 P† 0.99 0.78 0.87
Gestational glucose tolerance
 Normoglycemic 776 1.48 ± 1.22 33.8 ± 35.3 43.1 ± 50.6
 Isolated hyperglycemia 86 1.43 ± 1.21 35.8 ± 44.1 48.5 ± 51.7
 Impaired glucose tolerance 24 2.08 ± 1.35 33.0 ± 51.6 43.3 ± 64.4
 P† 0.16 0.81 0.53
Mode of delivery
 Vaginal 695 1.46 ± 1.20 34.1 ± 36.5 43.2 ± 49.5
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Mean ± SD
N*
CRP (mg/L)
n = 885
IL-6 (pg/mL)
n = 879
TNF-α (units/mg)
n = 878
 C-section 191 1.61 ± 1.32 33.3 ± 37.7 45.2 ± 56.7
 P† 0.14 0.80 0.63
Childs sex
 Male 432 1.52 ± 1.29 33.1 ± 37.5 42.2 ± 46.5
 Female 454 1.47 ± 1.17 34.7 ± 36.0 45.0 ± 55.2
 P† 0.48 0.50 0.40
Fetal growth
 SGA (<10th percentile) 53 1.48 ± 1.13 34.2 ± 28.2 42.5 ± 42.5
 AGA (10 to <90th percentile) 720 1.45 ± 1.21 33.5 ± 36.2 43.1 ± 49.2
 LGA (≥90th percentile) 113 1.81 ± 1.34 36.7 ± 43.2 47.2 ± 64.8
 P† 0.02 0.53 0.48
*
Totals may be <886 due to missing values.
†
Represents a test for linear trend in which the ordinal predictor is entered into the model as a continuous variable, except for race/ethnicity, 
smoking habits, partner’s BMI, and delivery method (Wald test).
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